Visgeneer Inc. (TPEX:4197)
Taiwan · Delayed Price · Currency is TWD 8.80
-0.19 (-2.11%)
Jul 21, 2026, 1:31 PM CST
Visgeneer Market Cap
Visgeneer has a market cap or net worth of 271.33 million as of July 21, 2026. Its market cap has decreased by -14.38% in one year.
Market Cap
271.33M
Enterprise Value
306.73M
Revenue
179.06M
Ranking
n/a
PE Ratio
51.71
Stock Price
8.80
ChartMarket Cap Chart
Since October 24, 2013, Visgeneer's market cap has decreased from 898.66M to 271.33M, a decrease of -69.81%. That is a compound annual growth rate of -8.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 271.33M | -7.32% |
| Dec 31, 2025 | 292.75M | -0.72% |
| Dec 31, 2024 | 294.87M | -8.69% |
| Dec 29, 2023 | 322.94M | 1.90% |
| Dec 30, 2022 | 316.90M | -17.97% |
| Dec 30, 2021 | 386.32M | -8.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Advance Bio-Pharmaceutical | 890.10M |
| NatureWise Biotech & Medicals | 800.93M |
| BioLASCO Taiwan | 761.96M |
| Neith | 710.20M |
| MegaPro Biomedical | 692.51M |
| SynCore Biotechnology Co.,Ltd | 685.71M |
| Vectorite Biomedical | 617.18M |
| TaiwanJ Pharmaceuticals | 552.84M |